Literature DB >> 33686466

Substance use among adolescents and young adults with chronic kidney disease or kidney failure.

Nianzhou Xiao1, Hua Chai2, Abiodun Omoloja3,4.   

Abstract

Substance use, a significant public health issue, is well described in the adult chronic kidney disease (CKD) population. Knowledge about substance use in the adolescent and young adult (AYA) CKD population such as prevalence, impact on kidney function, medication adherence, and psychosocial well-being remain largely unknown. Awareness of and inquiring about substance use is paramount to providing evidence-based care and preparation to transition to adult-focused health services. The authors in this review identify commonly used substances (alcohol, tobacco, marijuana, etc.) and how they impact kidney function and care of the AYA with CKD or kidney failure. Recommendations for screening and intervention strategies are provided.
© 2021. IPNA.

Entities:  

Keywords:  Adolescents; Chronic kidney disease; Kidney failure; Substance use; Young adults

Mesh：

Year:  2021        PMID： 33686466     DOI： 10.1007/s00467-021-05001-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  77 in total

Review 1.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Authors:  R Andrew Chambers; Jane R Taylor; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

2.  Cigarette smoking and progression of IgA nephropathy.

Authors:  Ryohei Yamamoto; Yasuyuki Nagasawa; Tatsuya Shoji; Hirotsugu Iwatani; Takayuki Hamano; Noritaka Kawada; Kazunori Inoue; Takuya Uehata; Tetsuya Kaneko; Noriyuki Okada; Toshiki Moriyama; Masaru Horio; Atsushi Yamauchi; Yoshiharu Tsubakihara; Enyu Imai; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Am J Kidney Dis       Date:  2010-05-14       Impact factor: 8.860

3.  Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.

Authors:  Joshua D Bundy; Lydia A Bazzano; Dawei Xie; Janet Cohan; Jacqueline Dolata; Jeffrey C Fink; Chi-Yuan Hsu; Kenneth Jamerson; James Lash; Gail Makos; Susan Steigerwalt; Xue Wang; Katherine T Mills; Jing Chen; Jiang He
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-07       Impact factor: 8.237

4.  Hookah use among U.S. high school seniors.

Authors:  Joseph J Palamar; Sherry Zhou; Scott Sherman; Michael Weitzman
Journal:  Pediatrics       Date:  2014-07-07       Impact factor: 7.124

5.  Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.

Authors:  Stephan R Orth; Torsten Schroeder; Eberhard Ritz; Paolo Ferrari
Journal:  Nephrol Dial Transplant       Date:  2005-07-26       Impact factor: 5.992

6.  Use of Flavored E-Cigarettes Among Adolescents, Young Adults, and Older Adults: Findings From the Population Assessment for Tobacco and Health Study.

Authors:  Samir S Soneji; Kristin E Knutzen; Andrea C Villanti
Journal:  Public Health Rep       Date:  2019-03-12       Impact factor: 2.792

7.  Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease.

Authors:  Abiodun Omoloja; Judith Jerry-Fluker; Derek K Ng; Alison G Abraham; Susan Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2013-04-13       Impact factor: 3.714

8.  Age of drinking onset, alcohol use disorders, frequent heavy drinking, and unintentionally injuring oneself and others after drinking.

Authors:  Ralph W Hingson; Wenxing Zha
Journal:  Pediatrics       Date:  2009-06       Impact factor: 7.124

9.  Cigarette smoking and chronic allograft nephropathy.

Authors:  Nina Zitt; Barbara Kollerits; Ulrich Neyer; Walter Mark; Dorothea Heininger; Gert Mayer; Florian Kronenberg; Karl Lhotta
Journal:  Nephrol Dial Transplant       Date:  2007-05-21       Impact factor: 5.992

10.  Impact of tobacco control policies on adolescent smokeless tobacco and cigar use: a difference-in-differences approach.

Authors:  Summer Sherburne Hawkins; Nicoline Bach; Christopher F Baum
Journal:  BMC Public Health       Date:  2018-02-15       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.